Alkermes (ALKS) Cash & Equivalents (2010 - 2026)

Alkermes (ALKS) has 17 years of Cash & Equivalents data on file, last reported at $351.6 million in Q1 2026.

• Cash & Equivalents for Q1 2026 came in at $351.6 million, down 12.07% year-over-year; the trailing twelve-month figure through Mar 2026 was $351.6 million (down 12.07% YoY), and the FY2025 annual result was $388.6 million, up 33.46% from the prior year.
• Cash & Equivalents declined to $351.6 million in Q1 2026 per ALKS's latest filing, from $388.6 million in the prior quarter.
• Over five years, Cash & Equivalents peaked at $665.8 million in Q2 2023 and troughed at $254.6 million in Q2 2022.
• A 5-year average of $418.1 million and a median of $396.3 million in 2024 frame the typical range for Cash & Equivalents.
• The sharpest annual moves came in 2023 and 2024: Cash & Equivalents surged 161.46% in 2023, then tumbled 38.82% in 2024.
• A 5-year view of Cash & Equivalents shows it stood at $292.5 million in 2022, then jumped by 56.41% to $457.5 million in 2023, then slumped by 36.36% to $291.1 million in 2024, then soared by 33.46% to $388.6 million in 2025, then fell by 9.53% to $351.6 million in 2026.
• Business Quant data shows ALKS's Cash & Equivalents at $351.6 million in Q1 2026, $388.6 million in Q4 2025, and $616.4 million in Q3 2025.